Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021

SELL
$14.49 - $20.72 $12.5 Million - $17.9 Million
-865,072 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$14.61 - $22.14 $12.6 Million - $19.2 Million
865,072 New
865,072 $18.3 Million
Q2 2020

Aug 14, 2020

SELL
$10.89 - $21.47 $5.45 Million - $10.7 Million
-500,000 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$10.23 - $24.56 $5.12 Million - $12.3 Million
500,000 New
500,000 $5.87 Million

Others Institutions Holding HRTX

About HERON THERAPEUTICS, INC.


  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $211M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track Iron Triangle Partners LP Portfolio

Follow Iron Triangle Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Iron Triangle Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Iron Triangle Partners LP with notifications on news.